U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07940049) titled 'CovaRisk: Validating a Digital Tool for Ovarian Cancer Risk Assessment and Referral' on Oct. 11.
Brief Summary: Ovarian cancer is frequently diagnosed at an advanced stage, while its early symptoms are often nonspecific . In women presenting with an adnexal mass, clinicians must integrate clinical symptoms, menopausal status, tumour markers, ultrasound findings, cross-sectional imaging, and hereditary risk when deciding whether a patient requires urgent gynaecologic oncology referral, specialist review, additional imaging, or conservative follow-up . Existing validated tools address individual components of this pathway, but these t...